Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) is hosting a technical briefing session for analysts and investors today.
During the session the company will be discussing the clinical applications of its medical devices, its product technologies and its multiple distribution channels.
The company will provide a preview of its new flow generator product range for the treatment of obstructive sleep apnea, which will be introduced later this financial year. The new product range features a very compact design and will include models which incorporate combinations of the company’s innovative technologies, including SensAwake, Auto pressure setting, ThermoSmart and SmartStick.
A copy of the technical briefing presentation is available on request from the company by emailing:
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company visit www.fphcare.com.
Contact: Michael Daniell MD/CEO on +64 9 574 0161 or Tony Barclay CFO on +64 9 574 0119.
Technical Briefing for Analysts & Investors
Evidence and guidance for delivering Optiflow NHF, proven respiratory support for your patients.
Providing Optimal Humidity for intubated patients
Full face masks designed for comfort and care
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment